Acurx Pharmaceuticals, Inc.
Developing a new class of antibiotics to treat priority Gram-positive bacterial infections.
ACXP | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 259 LIBERTY AVENUE, 10305 STATEN ISLAND
- Website:
- https://www.acurxpharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Acurx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of antibiotics to treat infections caused by priority bacterial pathogens. The company's therapeutic candidates utilize a novel mechanism of action, targeting the bacterial enzyme DNA polymerase IIIC (Pol IIIC). This approach is designed to create antibiotics with a Gram-positive selective spectrum (GPSS®) for treating infections caused by bacteria such as Clostridium difficile, Enterococcus, and Staphylococcus.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Acurx Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Acurx Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Acurx Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
